Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 5—May 2010

Dispatch

Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA

Robin L.P. Jump, Michelle M. Riggs, Ajay K. Sethi, Michael J. Pultz, Tracie Ellis-Reid, William Riebel, Dale N. Gerding, Robert A. Salata, and Curtis J. DonskeyComments to Author 
Author affiliations: University Hospitals of Cleveland, Cleveland, Ohio, USA (R.L.P. Jump, R.A. Salata); Cleveland Veterans Affairs Medical Center, Cleveland (M.M. Riggs, M.J. Pultz, T. Ellis-Reid, C.J. Donskey); Case Western Reserve University, Cleveland (A.K. Sethi); Lakewood Hospital, Lakewood, Ohio, USA (W. Riebel); Hines Veterans Affairs Hospital, Hines, Illinois, USA (D.N. Gerding); Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA (D.N. Gerding)

Main Article

Table

Clostridium difficile infection rates and healthcare facility characteristics according to respiratory fluoroquinolone on formulary, Cleveland, Ohio, USA, 2006*

CharacteristicLevofloxacinMoxifloxacinNeither†Total
No. hospitals138122
No. beds, median (IQR)
232 (108–371)
361 (217–565)
1,008
316 (125–424)
Type of facility
Tertiary care0213
Acute care96015
Long-term acute care
4
0
0
4
Hospital system
System 11506
System 2110112
Neither
1
3
0
4
No. cases of C. difficile infection4945692061,269
Patient-days580,893666,719293,8331,541,445
Rate of C. difficile infection/10,000 patient-days, median (IQR)8.5 (7.8–9.3)8.5 (7.8–9.2)7.0 (6.1–8.0)8.2 (7.8–8.7)

*IQR, interquartile range.
†Ciprofloxacin on formulary but no respiratory fluoroquinolone on formulary.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO